Fifteen-year clinical prognosis and cardiovascular or limb event associated with homocysteine levels in peripheral arterial disease
Journal of Cardiology · 2023-11 · 82 (5) · 423-428
DOI: 10.1016/j.jjcc.2023.04.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiology, 2023-11. Verfasst von Hisao Kumakura und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Cardiovascular Hospital of Central Japan (Kitakanto Cardiovascular Hospital), Gunma, Japan. Electronic address…. Hauptthemen laut MEDLINE: Peripheral Arterial Disease, Diabetes Mellitus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: There are limited reports on the relationship between plasma homocysteine (Hcy) levels and long-term all-cause death (ACD), cardiovascular events, or limb events in patients with peripheral arterial disease (PAD). We examined the relationship between plasma Hcy levels and 15-year these events in PAD patients. METHODS: We performed a prospective cohort study in 955 PAD patients. The patients were divided into four groups based on plasma Hcy levels with median (interquartile range). The endpoints were cumulative incidences of ACD, major adverse cardiovascular events (MACE), and MACE plus limb events (MACLE). RESULTS: The incidences of ACD, MACE, and MACLE were correlated with plasma Hcy levels (P < 0.05). In multiple regression analysis, plasma Hcy had positive correlations with C-reactive protein (CRP), men, and critical limb ischemia (CLI) and negative correlations with estimated glomerular filtration rate (eGFR) and high-density lipoprotein cholesterol (p < 0.05). In Cox multivariate analysis, higher Hcy (HR 1.614, 95 % CI 1.229-2.119, p = 0.001), age, CRP, brain natriuretic peptide (BNP), D-dimer, lower body mass index, ankle brachial pressure index (ABI), serum albumin, eGFR, CLI, coronary heart disease (CHD), cerebrovascular disease, and diabetes were related to ACD; higher Hcy (HR 1.242, 95 % CI 1.004-1.535, p = 0.045), age, BNP, lower ABI, serum albumin, diabetes, and CHD were related to MACE; and higher Hcy (HR 1.290, 95 % CI 1.057-1.574, p = 0.012), BNP, lower ABI, serum albumin, CHD, and diabetes were related to MACLE (P < 0.05). Statins improved ACD, MACE, and MACLE (p < 0.01). CONCLUSIONS: Plasma Hcy was a risk factor for 15-year ACD, MACE, and MACLE in patients with PAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Cardiovascular Hospital of Central Japan (Kitakanto Cardiovascular Hospital), Gunma, Japan. Electronic address: kumakura@r.sannet.ne.jp.
- Department of Cardiovascular Medicine, Cardiovascular Hospital of Central Japan (Kitakanto Cardiovascular Hospital), Gunma, Japan.
- Department of Cardiovascular Surgery, Cardiovascular Hospital of Central Japan (Kitakanto Cardiovascular Hospital), Gunma, Japan.
Zitieren
APA
Kumakura, H., Funada, R., Matsuo, Y., Iwasaki, T., Nakashima, K., Tsuboi, E., & Ichikawa, S. (2023). Fifteen-year clinical prognosis and cardiovascular or limb event associated with homocysteine levels in peripheral arterial disease. Journal of Cardiology, 82(5), 423-428. https://doi.org/10.1016/j.jjcc.2023.04.021
Vancouver
Kumakura H, Funada R, Matsuo Y, Iwasaki T, Nakashima K, Tsuboi E, et al. Fifteen-year clinical prognosis and cardiovascular or limb event associated with homocysteine levels in peripheral arterial disease. Journal of Cardiology. 2023;82(5):423-428. doi:10.1016/j.jjcc.2023.04.021
BibTeX
@article{Kumakura2023,
author = {Kumakura, Hisao and Funada, Ryuichi and Matsuo, Yae and Iwasaki, Toshiya and Nakashima, Kuniki and Tsuboi, Eitoshi and Ichikawa, Shuichi},
title = {Fifteen-year clinical prognosis and cardiovascular or limb event associated with homocysteine levels in peripheral arterial disease},
journal = {Journal of Cardiology},
year = {2023},
volume = {82},
number = {5},
pages = {423--428},
doi = {10.1016/j.jjcc.2023.04.021}
}
EUVIMED